Current Oncology

Established in 1994, Current Oncology is a peer-reviewed, Canadian based and Internationally distributed journal. Published bi-monthly plus special supplemental issues, Current Oncology represents a multidisciplinary medium encompassing health care workers in the field of cancer therapy to report upon and to review progress in the management of this disease. Current Oncology is published by Multimed Inc.

Current Oncology is indexed/covered in PubMed, EMBASE (Excerpta Medica Database), Scopus, Journal Selector, Crossref, Index Copernicus, DOAJ (Directory of Open Access Journals), Google Scholar, EMCare, EBSCOhost.com Research Databases, Science Citation Index Expanded (SciSearch), and Journal Citation Reports/Science Edition. Following publication in Current Oncology, the full text of each article is available immediately and archived in PubMed Central (PMC), the U.S. National Library of Medicine's digital archive of biomedical and life sciences journal literature. It is also available in the databases of 100 libraries worldwide, and is a participant of the HINARI program.



The information provided on the Current Oncology website is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.

Announcements

 

Journal Announcement: New Impact Factor of 2.048 for Current Oncology!

 

We are pleased to announce to our readers that Current Oncology’s 2016 Impact Factor has increased to 2.048! This is an increase from our 2015 stats, where we received an impact factor of 1.829.

The journal impact factor is a measure of citation frequency that reflects the average number of citations to articles published in science and social science journals. Impact factors are calculated annually for those journals that are indexed in Thomson Reuters Journal Citation Reports. The impact factor of a journal in a given year is the average number of citations a paper published in that journal received during the two previous years. The impact factor is often used to rank the relative importance and scientific caliber of a journal within its field.

Our 2016 Impact Factor is a significant achievement for the journal, and demonstrates the increased recognition of Current Oncology in the field, and the improved relevance and quality of our articles. Thank you to our team of Editors and Section Editors, Reviewers and Authors for their valuable contribution to the journal. We look forward to continued success in 2017 as the journal continues to strengthen and grow!

Multimed Inc.
Publisher of Current Oncology

 
Posted: 2017-06-29 More...
 

Journal Announcement: Multimed Inc. partners with TrendMD to help Current Oncology readers discover the article they want to read next

 

What to read next? To address the challenge of helping readers find the most relevant research across an ever-growing number of articles online, we have partnered with TrendMD, the world’s leading scholarly research recommendation engine. Now our readers can quickly discover article recommendations related to what they just finished reading in the moment, without another search.

From an article page on Current Oncology, readers will see “We recommend…. powered by TrendMD.” The recommended articles are selected based on sophisticated algorithms applied across millions of articles served each month and based on actual reader click behavior (“people that read X, also clicked on Y”), similar to what one expects at Amazon, Netflix, and Spotify.

 
Posted: 2017-06-28 More...
 

Current Oncology is pleased to announce our new partnership with CAPO

 

We are pleased to announce that Current Oncology has partnered with the Canadian Association of Psychosocial Oncology (CAPO). The partnership will help promote relevant research, critical findings, and journal related news to CAPO members, and our readers will be kept informed of relevant CAPO activities, including conferences and important psychosocial oncology research.  Other highlights of the partnership include:

  • Current Oncology is now the endorsed publication of the society
  • Publication of CAPO Conference Abstracts and Practice Guidelines in Current Oncology
  • Discounted author fees for CAPO members – we encourage members to consider publishing their important work related to psychosocial research and education in Current Oncology
  • Current Oncology to sponsor CAPO’s Student Travel Conference Award

We are excited to work with CAPO, and welcome and encourage other societies across Canada to partner with us as we continue our mission of educating and sharing knowledge with members of the Canadian oncology community. For more information about partnership opportunities, please contact Amanda Shand (Amanda_Shand@multi-med.com).

Multimed Inc.

Publisher of Current Oncology

 
Posted: 2017-03-01 More...
 
More Announcements...

Vol 24, No 3 (2017)

Table of Contents

Editorial(s)

K.I. Stajduhar, A. Mollison, D. Gleave, S.W. Hwang
149-150

Commentary(ies)

M. Chasen, S. Hollingshead, H. Conter, R. Bhargava
151-152
R.S. Lim, A.Z. Kielar, R.H. El-Maraghi, M.A. Fraser, C. Nessim, S. Thipphavong
e171-e175
M. Clemons, A.A. Joy, J. Hilton, A. Arnaout, M. Brackstone, P. Wheatley-Price, C. Stober, R. Dinniwell, S. Mazzarello, M. da Costa, B. Hutton
e176-e179

Original Article(s)

Biomarkers in Oncology

S. Sun, Z. Chen, C. Cao, B. Wu, B. Wang, Y. Yu, Z. Chen, Z. Hu, Z. Deng
e180-e184

Cancer Control and Prevention

W.K. Evans, R. Truscott, E. Cameron, A. Peter, R. Reid, P. Selby, P. Smith, A. Hey
e185-e190

Cancer Rehabilitation and Survivorship

S. McEwen, C. Dunphy, J. Norman Rios, A. Davis, J. Jones, A. Lam, I. Poon, R. Martino, J. Ringash
153-160
M.A. Dalzell, N. Smirnow, W. Sateren, A. Sintharaphone, M. Ibrahim, L. Mastroianni, L.D. Vales Zambrano, S. O'Brien
e191-e198

Clinical Trials

A.E. Hay, Y.W. Leung, J.L. Pater, M.C. Brown, E. Bell, D. Howell, Z. Kassam, S. Willing, C. Tian, G. Liu
161-167

Geriatric Oncology

C. Bilir, S. Durak, B. Kızılkaya, I. Hacıbekiroglu, E. Nayır, H. Engin
e199-e204

Knowledge Translation

S. Tan, J. David, L. Lalonde, M. El Khoury, M. Labelle, R. Younan, E. Patocskai, J. Richard, I. Trop
e205-e213

Medical Economics

F. Gwadry-Sridhar, S. Nikan, A. Hamou, S.J. Seung, T. Petrella, A.M. Joshua, S. Ernst, N. Mittmann
168-175
M. Elmi, H. Hussain, S. Nofech-Mozes, B. Curpen, A. Leahey, N. Look Hong
e214-e219

Radiation Oncology

R.C.N. Studinski, D.J. Fraser, R.S. Samant, M.S. MacPherson
181-186
H. Vulpe, J.Y.Y. Kwan, A. McNiven, J.D. Brierley, R. Tsang, B. Chan, D.P. Goldstein, L.W. Le, A. Hope, M. Giuliani
e226-e232

Surgical Oncology

N.W. Molla, M.M. Hassanain, Z. Fadel, L.M. Boucher, A. Madkhali, R.M. Altahan, E.A. Alrijraji, E.B. Simoneau, H. Alamri, A. Salman, Z. Gao, P.P. Metrakos
e233-e243

Review Article(s)

Practice Guideline(s)

L. Barbera, C. Zwaal, D. Elterman, K. McPherson, W. Wolfman, A. Katz, A. Matthew, and the Interventions to Address Sexual Problems in People with Cancer Guideline Development Group
192-200

Short Communication(s)

K. Tran, R. Rahal, S. Fung, G. Lockwood, C. Louzado, J. Xu, H. Bryant, in collaboration with the System Performance Steering Committee and Technical Working Group
201-206

Case Report(s)

B. Domingo-Arrué, R. Gil-Benso, J. Megías, L. Navarro, T. San-Miguel, L. Muñoz-Hidalgo, C. López-Ginés, M. Cerdá-Nicolás
e244-e250
N. Chooback, Y. Shen, M. Jones, K. Kasaian, M. Martin, T. Ng, T. Thompson, M. Marra, J. Laskin, C. Ho
e251-e254